Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P DePriest

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|April 11, 2001
What's in a PhyloCode name?W J Kress, P DePriest
Cureus|November 29, 2023
Quadratus Lumborum Blocks for Pediatric Bone Marrow Harvesting: A Case ReportNicole C McCoy, Brittany P DePriest
Cancer|June 15, 1993
Clinical evaluation of 252Cf neutron intracavitary therapy for primary endometrial adenocarcinomaY Maruyama, J R Van Nagell, J Yoneda, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancerY Maruyama, M G Bowen, J R Van Nagell, et al.
American Journal of Clinical Oncology|April 1, 1993
Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trialY Maruyama, J R van Nagell, J Yoneda, et al.
Gynecologic Oncology|September 11, 1991
The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activationE J Pavlik, K Nelson, J R van Nagell, et al.
JCI Insight|April 18, 2023
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantationYan Han, Alan Bidgoli, Brittany P DePriest, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|April 11, 2001
What's in a PhyloCode name?W J Kress, P DePriest
Cureus|November 29, 2023
Quadratus Lumborum Blocks for Pediatric Bone Marrow Harvesting: A Case ReportNicole C McCoy, Brittany P DePriest
Cancer|June 15, 1993
Clinical evaluation of 252Cf neutron intracavitary therapy for primary endometrial adenocarcinomaY Maruyama, J R Van Nagell, J Yoneda, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancerY Maruyama, M G Bowen, J R Van Nagell, et al.
American Journal of Clinical Oncology|April 1, 1993
Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trialY Maruyama, J R van Nagell, J Yoneda, et al.
Gynecologic Oncology|September 11, 1991
The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activationE J Pavlik, K Nelson, J R van Nagell, et al.
JCI Insight|April 18, 2023
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantationYan Han, Alan Bidgoli, Brittany P DePriest, et al.
Pageof 1